• Demir M, Telli-Dizman G, Hazırolan G, Uzun Ö, Metan G. The Impact of Reporting the Same-Day Identification and Antibiotic Susceptibility Test Results on the Treatment of Bloodstream Infections. Infect Dis Clin Microbiol. 2024 Jun 28;6(2):123-132. doi: 10.36519/idcm.2024.334. PMID: 39005703; PMCID: PMC11243774.

          https://pubmed.ncbi.nlm.nih.gov/39005703/

 

• Doğan CZ, Yalçın N, Cennet Ö, Metan G, Demirkan K, Yorgancı K. Optimization of appropriate antimicrobial prophylaxis in general surgery: a prospective cohort study. Eur J Med Res. 2024 Jun 19;29(1):340. doi: 10.1186/s40001-024-01938-w. PMID: 38890673; PMCID: PMC11186073.

          https://pubmed.ncbi.nlm.nih.gov/38890673/

 

• Özdede M, Zarakolu P, Metan G, Köseoğlu Eser Ö, Selimova C, Kızılkaya C, Elmalı F, Akova M. EXPRESS: Predictive Modeling of Mortality in Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections Using Machine Learning. J Investig Med. 2024 Jun 13:10815589241258964. doi: 10.1177/10815589241258964. Epub ahead of print. PMID: 38869153.

          https://pubmed.ncbi.nlm.nih.gov/38869153/

 

• Özden A, Dalgıç B, Demir M, Hazırolan G, Uzun Ö, Metan G. Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations. J Chemother. 2024 May;36(3):190-197. doi: 10.1080/1120009X.2023.2296146. Epub 2023 Dec 22. PMID: 38131316.

          https://pubmed.ncbi.nlm.nih.gov/38131316/

 

• Ballı FN, Ekinci PB, Kurtaran M, Kara E, Dizman GT, Sönmezer MÇ, Hayran M, Demirkan K, Metan G. Battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin. Int J Antimicrob Agents. 2024 Feb;63(2):107035. doi: 10.1016/j.ijantimicag.2023.107035. Epub 2023 Nov 17. PMID: 37979889.

          https://pubmed.ncbi.nlm.nih.gov/37979889/

 

• Marrs ECL, Milburn O, Eltringham GJ, Fenwick DJC, Orenga S, Hazirolan G, Zarakolu P, Perry JD.  The use of CHROMID® Colistin R for the detection of colistin resistant gram-negative bacteria in positive blood cultures. Antibiotics 2024;13: 246, doi.org/10.3390/antibiotics13030246

           https://pubmed.ncbi.nlm.nih.gov/38534681/

 

• Tau N, Akova M, Barac A, Nasim A, Righi E, Yahav D, ESCMID Ethics Advisory Committee (EEAC). Scinetific misconduct in infectious diseases - European Society of Clinical Microbiology and Infectious Diseases survey. Clin Microbiol Infect 2024 Jul 25: S1198-743x(24)00344-6. doi: 10.1016/j.cmi.2024.07.015. 

           https://pubmed.ncbi.nlm.nih.gov/39067515/

 

• Kilinc EE, Bayraktar I, Kara E, Demirkan K, Akova M. Beyond conventional dosing: tailoring antimicrobial regimens for cachexia. Eur J Hosp Pharm 2024 Jul24: ejhpharm-2024-004250. doi: 10.1136/ejhpharm-2024-004250.

           https://pubmed.ncbi.nlm.nih.gov/39048297/

 

• Salmanton-Garcia J, Cornely OA, Stemler J, Barać A, Steinmann J, Siváková A, Akalin EH, Arikan-Akdagli S, Loughlin L, Toscano C, Narayanan M, Rogers B, Willinger B, Akyol D, Roilides E, Lagrou K, Mikulska M, Denis B, Ponscarme D, Scharmann U, Azap A, Lockhart D, Bicanic T, Kron F, Erben N, Rautemaa-Richardson R, Goodman AL, Garcia-Vidal C, Lass-Flörl C, Gangneux JP, Taramasso L, Ruiz M, Schick Y, Van Wijngaerden E, Milacek C, Giacobbe DR, Logan C, Rooney E, Gori A, Akova M, Bassetti M, Hoenigl M, Koehler P. Attributable mortality of candidemia. Results from the ECMM Candida III multinational European Observational Cohort Study. J Infect 2024 Sep;89(3): 106229. doi: 10.1016/j.jinf.2024.106229. 

 

     https://pubmed.ncbi.nlm.nih.gov/39025408/

• Stemler J, Yeghiazaryan L, Stephan C, Mohn KG, Carcas-Sansuan AJ, Rodriguez, ER, Moltó J, Mitxeltorena IV, Welte T, Zablockienė B, Akova M, Bethe U, Heringer S, Salmanton-García J, Jeck J, Tischmann L, Zarrouk M, Cüppers A, Biehl LM, Grothe J, Mellinghoff SC, Nacov JA, Neuhann JM, Sprute R, Frías-Iniesta J, Negi R, Gaillard C, Saini G, León AG, Mallon PWG, Lammens C, Hotterbeekx A, Loens K, Malhotra-Kumar S, Goossens H, Kumar-Singh S, König F, Posch M, Koehler P, Cornely OA; EU-COVAT-1 AGED study group on behalf of the VACCELERATE consortium. Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273: A randomized VACCELERATE trial in adults aged ≥75 years, (EU-COVAT-1-AGED Part B). Int J Infect Dis. 2024 Sep;146:107161. doi: 10.1016/j.ijid.2024.107161. 

          https://pubmed.ncbi.nlm.nih.gov/38992789/

 

• Zhou H, Buetti N, Pérez-Galera S, Bravo-Ferrer J, Gutiérrez-Gutiérrez B, Paniagua-García M, Feifel J, Sauser J, Kostyanev T, Canton R, Tan LK, Basoulis D, Pintado V, Roilides E, Dragovac G, Torre-Cisneros J, Mediç D, Akova M, Goossens H, Bonten M, Harbarth S, Rodriguez-Baño J, De Kraker MEA; COMBACTE-EURECA project team. Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control study. J Antimicrob Chemother 2024 Jul 11:dkae157. doi: 10.1093/jac/dkae157.

           https://pubmed.ncbi.nlm.nih.gov/38988305/

 

• Margalit I, Yahav D, Hoffman T, Tabah A, Ruckly S, Barbier F, Singer P, Timsit JF, Prendki V, Buetti N; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Groups for Infections in Critically Ill Patients (ESGCIP) and Infections in the Elderly (ESGIE), and the OUTCOMEREA Network. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study. Infection. 2024 Jun 13. doi: 10.1007/s15010-024-02304-y.

           https://pubmed.ncbi.nlm.nih.gov/38869773/

 

• Wozniak H, Tabah A, Barbier F, Ruckly S, Loiodice A, Akova M, Leone M, Conway, Morris A, Bassetti M, Arvaniti K, Ferrer R, de Bus L, Paiva JA, Bracht H, Mikstacki A, Alsisi A, Valeanu L, Prazak J, Timsit JF, Buetti N; EUROBACT-2 Study Group, ESICM, ESCMID ESGCIP and the OUTCOMEREA Network. Hospital-acquired bloodstream infections in critically ill cirrhotic patients: a post-hoc analysis of the EUROBACT-2 international cohort study. Ann Intensive Care 2024 May 2;14(1):70. doi: 10.1186/s13613-024-01299-x.

           https://pubmed.ncbi.nlm.nih.gov/38698291/

 

• Royo-Cebrecos C, Laporte-Amargós J, Peña M, Ruiz-Camps I, Garcia-Vidal C, Abdala E, Oltolini C, Akova M, Montejo M, Mikulska M, Martín-Dávila P, Herrera F, Gasch O, Drgona L, Morales HMP, Brunel AS, García E, Isler B, Kern WV, Palacios-Baena ZR, de la Calle GM, Montero MM, Kanj SS, Sipahi OR, Calik S, Márquez-Gómez I, Marin JI, Gomes MZR, Hemmatii P, Araos R, Peghin M, Del Pozo JL, Yáñez L, Tilley R, Manzur A, Novo A, Carratalà J, Gudiol C; IRONIC Study Group. Pseudomonas aeruginosa bloodstream infections presenting with septic shock in neutropenic cancer patients: Impact of empirical antibiotic therapy. Microorganisms. 2024 Mar 30;12(4):705. doi: 10.3390/microorganisms12040705. 

           https://pubmed.ncbi.nlm.nih.gov/38674650/

 

• Bassetti  M, Giacobbe DR, Agvald-Ohman C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot S, Cornely OA, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Koehler P, Kullberg BJ, Lamoth F, Lass-Flörl C, Maertens J, Martin-Loeches I, Muñoz P, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Wauters J, Asperges E, Cortegiani A, Grecchi C, Karaiskos I, Le Bihan C, Mercier T, Mortensen KL, Peghin M, Rebuffi C, Tejada S, Vena A, Zuccaro V, Scudeller L, Calandra T; Study Group for Infections in Critically Ill Patients of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG), the European Society of Intensive Care Medicine (ESICM), the European Confederation of Medical Mycology (ECMM), the Mycoses Study Group Education and Research Consortium (MSGERC), the International Society of Antimicrobial Chemotherapy (ISAC), the International Society for Human and Animal Mycology (ISHAM), the Austrian Society for Medical Mycology (ÖGMM), the Italian Society of Anesthesia, Analgesia, Reanimation, and Intensive Care (SIAARTI), the Italian Society of Anti-Infective Therapy (SITA), and the FUNDICU Collaborators. Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM. Intensive Care Med 2024 Apr;50(4):502-515. doi: 10.1007/s00134-024-07341-7. 

           https://pubmed.ncbi.nlm.nih.gov/38512399/

 

• Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections. Intensive Care Med. 2024 Jun;50(6):873-889. doi: 10.1007/s00134-024-07348-0. Erratum in: Intensive Care Med. 2024 Jun;50(6):1017-1018. doi: 10.1007/s00134-024-07415-6. 

            https://pubmed.ncbi.nlm.nih.gov/38498170/

 

• Paniagua-Garcia M, Bravo-Ferrer JM, Pérez-Galera S, Kostyanev T, de Kraker MEA, Feifel J, Palacios-Baena ZR, Schotsman J, Cantón R, Daikos GL, Carevic B, Dragovac G, Tan LK, Raka L, Hristea A, Viale P, Akova M, Cano Á, Reguera JM, Bartoloni A, Florescu SA, Benea S, Bukarica L, Asensio Á, Korten V, Grundmann H, Goossens H, Bonten MJ, Gutiérrez-Gutiérrez B, Rodríguez-Baño J; COMBACTE-CARE-EURECA team. Attributable mortality of infections caused by carbapenem-resistant Enterobacterales: results from a prospective, multinational case-control-control matched cohorts study (EURECA). Clin Microbiol Infect 2024 Feb;30(2):223-230. doi: 10.1016/j.cmi.2023.11.008.

           https://pubmed.ncbi.nlm.nih.gov/38267096/

 

• Teh BW, Mikulska M, Averbuch D, de la Camara R, Hirsch HH, Akova M, Ostrosky-Zeichner L, Baddley JW, Tan BH, Mularoni A, Subramanian AK, La Hoz  RM, Marinelli T, Boan P, Aguado JM, Grossi PA, Maertens J, Mueller NJ, Slavin MA. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients. Lancet Infect Dis 2024 Jan;24(1):e59-e68. doi: 10.1016/S1473-3099(23)00377-8. 

           https://pubmed.ncbi.nlm.nih.gov/37683684/

 

• Bakir Ekinci P, Kara E, Telli Dizman G, Metin S, Inkaya AC, Demirkan K, Coplu L, Unal S. Compliance with guideline recommendations in the management of patients with hospitalized community-acquired pneumonia. J Invest Med. 2024 Apr;72(4):349-358. doi: 10.1177/10815589241232366.

           https://pubmed.ncbi.nlm.nih.gov/38328895/

 

• Firat O, Kara E, Malkan ÜY, Demirkan K, Inkaya AÇ. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study. Thromb Res. 2024 Apr;236:155-160. doi: 10.1016/j.thromres.2024.03.003.

           https://pubmed.ncbi.nlm.nih.gov/38452447/

 

• Inkaya AC. Mpox: what sexual health physicians need to know? Int J Impot Res 2024 Aug 17. doi: 10.1038/s41443-024-00964-w.

           https://pubmed.ncbi.nlm.nih.gov/39154147/

 

• Akbulut I, Odemis I, Atalay S, Inkaya AC. Comparison of clinician preference and HIV-ASSIST recommendations in antiretroviral therapy decision-making: A single center experience from Turkiye. Int J STD AIDS. 2024 May;35(6):430-437. doi: 10.1177/09564624241229464. 

           https://pubmed.ncbi.nlm.nih.gov/38261725/

 

• Gokengin D, Noori T, Alemany A, Bienkowski C, Liegon G, İnkaya AÇ, Carrillo J, Stary G, Knapp K, Mitja O, Molina JM. Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe. Lancet Reg Health Eur. 2023 Oct 26;34:100738. doi: 10.1016/j.lanepe.2023.100738.

           https://pubmed.ncbi.nlm.nih.gov/37927439/

 

• Celik Ekinci S, Yenilmez E, Akengin Öcal G, Sonmezer MÇ, Tarakçı A, Aygün C, Akdag D, Seyman D, Asik C, Zerdali E, Yılmaz Karadag F, Kaya S, Celik M, Cifci S, Yıldız IE, Colkesen F, Akgul F, Aldemir O, Bozdag M, Ozer D, Hizmali L, Canbolat Unlu E, Gur Altunay D, Sahin A, Unlu G, Gencalioglu AE, Tekin Sahin S, Ozdemir Y, Unlu S, Singil S, Altıntas J, Akkaya Isik S, Gul O, Tuna N, Simsek S, Ozguler M, Elbir Kilic P, İsik ME, Karakus A, Kiratli K, Yardimci AC, Volkan S, Olcar Y, Cakir Y, Ozer Yilmaz N, Karaayvaz S, Batirel A, Duran ZC, Rasa HK, Kose S. Surgical Antimicrobial Prophylaxis Compliance in Turkey: Data from the Prospective, Observational, Multicenter Survey Including 7,978 Surgical Patients. Surg Infect (Larchmt). 2024 Apr;25(3):231-239. doi: 10.1089/sur.2023.243.

           https://pubmed.ncbi.nlm.nih.gov/38588521/

 

• Yaylali E, Erdogan ZM, Calisir F, Pullukcu H, Yildirim F, Inan A, Aydin OA, Tekin S, Sonmezer MC, Sahin T, Ozcagli TG, Ozelgun B. Rapid initiation of antiretroviral therapy in Turkey: a modeling study. Front Public Health. 2024 Jan 26;12:1224449. doi: 10.3389/fpubh.2024.1224449.

           https://pubmed.ncbi.nlm.nih.gov/38344235/ 

 

• Taş Z, Metan G, Dizman GT, Yavuz E, Dizdar Ö, Büyükaşık Y, Uzun Ö, Akova M. An institutional febrile neutropenia protocol improved antibacterial treatment and encuraged the development of a computerized clinical decision support system. Antibiotics 2024;13:832. doi: 10.3390/antibiotics13090832.

            https://pubmed.ncbi.nlm.nih.gov/39335006/

 

• Boşnak C, Fındık ŞB, Atay, M, Fakhouri W, Babazade S, Karadogan E, Metan G, Uzun Ö. The impact of hospital-specific guidelines on carbapenem use and patient outcomes in a setting for high endemicity with multidrug-resistant gram-negative bacilli. Antimicrob Steward Healthc Epidemiol 2024;4:e146. doi: 10.1017/ash.2024.415.

            https://pubmed.ncbi.nlm.nih.gov/39346671/

 

• Alkan A, Buyukasik Y, Uzun O, Demir AU, Coplu L. Invasive fungal infections in patients with acute leukemia: A retrospective cohort study at a tertiary-care hospital. Medicine (Baltimore) 2024 Oct 4;103 (40) e39959. doi: 10.1097/MD.0000000000039959.

           https://pubmed.ncbi.nlm.nih.gov/39465746/

 

• Balaban U, Kara E, Kaya EK, Ozcebe OI, Akova M, Topeli A, Yorganci K, Demirkan K. Effect of therapeutic plasma exchange on antimicrobials in critically ill patients . Crit Care 2024 Aug 28;28:280. doi: 10.1186/s13054-024-05077-w.

           https://pubmed.ncbi.nlm.nih.gov/39198857/

 

• Aslan AT, Akova M. Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies. Expert Rev Anti Infect Ther 2024 Sep 29:1-17. doi: 10.1080/14787210.2024.2408746.

           https://pubmed.ncbi.nlm.nih.gov/39313753/

 

• Er AG, Aslan AT, Mikulska M, Akova M. Prevention adn treatment of bacterial infections in patients with haematological cancers and haematological stem cell transplantation: headways and shortcomings. Clin Microbiol Infect. 2024 Sep 25:S1198-743X(24)00447-6. doi: 10.1016/j.cmi.2024.09.015.

           https://pubmed.ncbi.nlm.nih.gov/39332598/

 

• Aslan AT, Akova M, Kontoyiannis DP. The heterogeneous syndrome of non-infectious causes of persistent fever in neutropenic patients with hematologic malignancy: another opportunity for stewardship? Clin Infect Dis. 2024 Oct 14:ciae487. doi: 10.1093/cid/ciae487.

          https://pubmed.ncbi.nlm.nih.gov/39397538/

 

• Righi E, Mirandola M, Grossi AA, Akova M, Tacconelli E, Fratucello A, Nasim A, Barac A, Yahav D. Infectious diseases ethics: A worldwide survey. Clin Microbiol Infect. 2024 Oct 26:S1198-743X(24)00503-2. doi: 10.1016/j.cmi.2024.10.021.

           https://pubmed.ncbi.nlm.nih.gov/39490409/

 

• Stemler J, Gavriilaki E, Hlukhareva O, Khanna N, Neofytos D, Akova M, Pagano L, Cisneros JM, Cornely OA, Salmanton-García J. Current practice of screening and antimicrobial prophylaxis to prevent Gram-negative bacterial infection in high-risk haematology patients: Results from a pan-European surrvey. Ther Adv Infect Dis. 2024 Oct 29;11:20499361241271863. doi: 10.1177/20499361241271863.

           https://pubmed.ncbi.nlm.nih.gov/39493728/

 

• Sahin TK, Sonmezer MC. The role of the microbiome in head and neck squamous cell cancers. Eur Arch Otorhinolaryngol. 2024 Sep 21. doi: 10.1007/s00405-024-08966-6.

            https://pubmed.ncbi.nlm.nih.gov/39306588/

 

• Balli Turhan FN, Kara E, Uyaroğlu OA, Çalık Başaran N, Demirkan K, Ünal S, İnkaya AÇ. Evaluation of infectious diseases physicians' attitudes to dyslipidemia management in PLWH. Postgrad Med. 2024 Sep;136(7):720-725. doi: 10.1080/00325481.2024.2394015.

           https://pubmed.ncbi.nlm.nih.gov/39175150/

 

• Alkan B, Tuncer MA, İnkaya AÇ. Advances in virus-specific T-cell therapy for polyomavirus infections. A comprehensive review. Int J Antimicrob Agents. 2024 Nov;64(5):107333. doi: 10.1016/j.ijantimicag.2024.107333.

           https://pubmed.ncbi.nlm.nih.gov/39245328/

 

• Inkaya AC. Mpox: What sexual health physicians need to know? Int J Impot Res. 2024 Sep;36(6):556-561. doi: 10.1038/s41443-024-00964-w.

           https://pubmed.ncbi.nlm.nih.gov/39154147/

 

• Bakir Ekinci P, Kara E, Er AG, Pinar A, Inkaya AC, Demirkan K, Metan G, Uzun O. Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis. J Infect Dev Ctries 2024 Oct 31;18(10):1617-1624. doi: 10.3855/jidc.19290.

            https://pubmed.ncbi.nlm.nih.gov/39616493/

 

• Ucdal M, Kara E, Berker M, Pinar A, Gulmez D, Arikan-Akdagli S, Cağkan Inkaya A, Metan G. Monitoring of the cerebrospinal fluide voriconazole level in a patient with recurrent Candida meningitis after pituitary surgery. Int J Antimicrob Agents. 2024 Dec;64(6):107379. doi: 10.1016/j.ijantimicag.2024

           https://pubmed.ncbi.nlm.nih.gov/39515487/